Skip to main content

AJOONI · Ajooni Biotech Limited · Financials

3.13 INR +0.26 (+9.06%) At close · Nov 13
Market Cap
567.29M INR
Shares
181.24M
Volume · Nov 13 4.35M Avg daily vol (3M) 396.42K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Revenue
1.82B +59%
FY2026 Revenue FY2021–FY2026
Net Income
43.22M +28.2%
FY2026 Net Income FY2021–FY2026
Operating Cash Flow
-57.34M +67.7%
FY2026 Operating Cash Flow FY2022–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2026 FY2025 FY2024 FY2023 FY2022 FY2021
INR 2.48B 1.82B 1.15B 801.15M 744.88M 740.38M 510.39M
INR 34.35M 22.06M 10.94M 8.74M 10.05M 11.11M 5.78M
INR 16.66M 7.29M 3.34M 5.57M 4.78M 5.4M 5.84M
INR 48.37M 57.38M 43.29M 29.96M 15.77M 14.61M 5.04M
INR 12.99M 14.16M 9.57M 8.35M 4.52M 4.12M 1.31M
INR 35.38M 43.22M 33.72M 21.61M 11.25M 10.49M 0
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 0 in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.